These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9545623)

  • 1. Cardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women.
    Waluga M; Janusz M; Karpel E; Hartleb M; Nowak A
    Clin Physiol; 1998 Jan; 18(1):69-76. PubMed ID: 9545623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y in obese women during treatment with adrenergic modulation drugs.
    Zahorska-Markiewicz B; Obuchowicz E; Waluga M; Tkacz E; Herman ZS
    Med Sci Monit; 2001; 7(3):403-8. PubMed ID: 11386016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular changes after treatment with dexfenfluramine and yohimbine in obese women measured by thoracic electrical bioimpedance.
    Waluga M; Janusz M; Karpel E; Hartleb M; Nowak A
    Boll Chim Farm; 1999; 138(7):359-63. PubMed ID: 10597657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
    Astrup A; Lundsgaard C
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():29-34. PubMed ID: 9792479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anti-obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patients.
    Jonderko K; Kucio C
    Aliment Pharmacol Ther; 1991 Aug; 5(4):413-8. PubMed ID: 1777550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain.
    Nørregaard J; Jørgensen S; Mikkelsen KL; Tønnesen P; Iversen E; Sørensen T; Søeberg B; Jakobsen HB
    Clin Pharmacol Ther; 1996 Dec; 60(6):679-86. PubMed ID: 8988071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects.
    Magkos F; Kavouras SA
    Sports Med; 2004; 34(13):871-89. PubMed ID: 15487903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is an ephedrine caffeine treatment contraindicated in hypertension?
    Ingerslev J; Svendsen TL; Mørk A
    Int J Obes Relat Metab Disord; 1997 Aug; 21(8):666-73. PubMed ID: 15481766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ephedrine, caffeine, and their combination on muscular endurance.
    Jacobs I; Pasternak H; Bell DG
    Med Sci Sports Exerc; 2003 Jun; 35(6):987-94. PubMed ID: 12783047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea.
    Diepvens K; Westerterp KR; Westerterp-Plantenga MS
    Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R77-85. PubMed ID: 16840650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of caffeine and ephedrine ingestion on anaerobic exercise performance.
    Bell DG; Jacobs I; Ellerington K
    Med Sci Sports Exerc; 2001 Aug; 33(8):1399-403. PubMed ID: 11474345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of caffeine, ephedrine and their combinations on time to exhaustion during high-intensity exercise.
    Morton RH
    Eur J Appl Physiol Occup Physiol; 1999 Mar; 79(4):379-81. PubMed ID: 10090640
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug treatment of obesity.
    Bray GA
    Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Apr; 13(1):131-48. PubMed ID: 10932681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
    Buemann B; Marckmann P; Christensen NJ; Astrup A
    Int J Obes Relat Metab Disord; 1994 May; 18(5):329-32. PubMed ID: 8061726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-prandial thermogenesis with ephedrine, caffeine and aspirin in lean, pre-disposed obese and obese women.
    Horton TJ; Geissler CA
    Int J Obes Relat Metab Disord; 1996 Feb; 20(2):91-7. PubMed ID: 8646257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of caffeine on metabolic and cardiovascular functions during sustained light intensity cycling and at rest.
    Engels HJ; Wirth JC; Celik S; Dorsey JL
    Int J Sport Nutr; 1999 Dec; 9(4):361-70. PubMed ID: 10660867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
    Astrup A; Breum L; Toubro S; Hein P; Quaade F
    Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of thermogenic drugs.
    Astrup A; Toubro S; Christensen NJ; Quaade F
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):246S-248S. PubMed ID: 1345887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ingesting caffeine and ephedrine on 10-km run performance.
    Bell DG; McLellan TM; Sabiston CM
    Med Sci Sports Exerc; 2002 Feb; 34(2):344-9. PubMed ID: 11828246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does yohimbine act as a slimming drug?
    Kucio C; Jonderko K; Piskorska D
    Isr J Med Sci; 1991 Oct; 27(10):550-6. PubMed ID: 1955308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.